Michael A. Taffe

Michael A. Taffe

Auto-generated profile, based on publicly available information

Michael A. Taffe

Department of Psychiatry, University of California, San Diego, La Jolla, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2017 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
DBDouglas L Boggs
Douglas L Boggs
JNJacques Nguyen
Jacques Nguyen
DMDaralyn Morgenson
Daralyn Morgenson
MTMichael A Taffe
Michael A Taffe
MRMohini Ranganathan
Mohini Ranganathan
The plant Cannabis sativa, commonly called cannabis or marijuana, has been used for its psychotropic and mind-altering side effects for millennia. There has been growing attention in recent years on its potential therapeutic efficacy as municipalities and legislative bodies in the United States, Canada, and other countries grapple with enacting policy to facilitate the use of cannabis or its constituents for medical purposes. There are >550 chemical compounds and >100 phytocannabinoids isolated from cannabis, including Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is thought to produce the main psychoactive effects of cannabis, while CBD does not appear to have similar effects. Studies conflict as to whether CBD attenuates or exacerbates the behavioral and cognitive effects of THC. This includes effects of CBD on THC-induced anxiety, psychosis, and cognitive deficits. In this article, we review the available evidence on the pharmacology and behavioral interactions of THC and CBD from preclinical and human studies, particularly with reference to anxiety and psychosis-like symptoms. Both THC and CBD, as well as other cannabinoid molecules, are currently being evaluated for medicinal purposes, separately and in combination. Future cannabis-related policy decisions should include consideration of scientific findings, including the individual and interactive effects of CBD and THC.

1 August 2013 in Neuropharmacology
Verified
Journal Article
Closed access
SAS.M. Aarde
S.M. Aarde
PHP.K. Huang
P.K. Huang
KCK.M. Creehan
K.M. Creehan
TDT.J. Dickerson
T.J. Dickerson
MTM.A. Taffe
M.A. Taffe

18 January 2021 in eLife
Verified
Journal Article
Open access
MTMichael A Taffe
Michael A Taffe
NGNicholas W Gilpin
Nicholas W Gilpin
Biomedical science and federal funding for scientific research are not immune to the systemic racism that pervades American society. A groundbreaking analysis of NIH grant success revealed in 2011 that grant applications submitted to the National Institutes of Health in the US by African-American or Black Principal Investigators (PIs) are less likely to be funded than applications submitted by white PIs, and efforts to narrow this funding gap have not been successful. A follow-up study in 2019 showed that this has not changed. Here, we review those original reports, as well as the response of the NIH to these issues, which we argue has been inadequate. We also make recommendations on how the NIH can address racial disparities in grant funding and call on scientists to advocate for equity in federal grant funding.

1 October 2016 in Neuropharmacology
Verified
Journal Article
Closed access
JNJacques Nguyen
Jacques Nguyen
SAShawn M. Aarde
Shawn M. Aarde
SVSophia A. Vandewater
Sophia A. Vandewater
YGYanabel Grant
Yanabel Grant
DSDavid G. Stouffer
David G. Stouffer
MTMichael A. Taffe
Michael A. Taffe

1 May 2015 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
SAShawn M. Aarde
Shawn M. Aarde
KCKevin M. Creehan
Kevin M. Creehan
SVSophia A. Vandewater
Sophia A. Vandewater
TDTobin J. Dickerson
Tobin J. Dickerson
MTMichael A. Taffe
Michael A. Taffe

16 June 2018 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
MJMehrak Javadi-Paydar
Mehrak Javadi-Paydar
JNJacques Nguyen
Jacques Nguyen
TKTony M. Kerr
Tony M. Kerr
YGYanabel Grant
Yanabel Grant
SVSophia A. Vandewater
Sophia A. Vandewater
MTMichael A. Taffe
Michael A. Taffe